Stephane Le Vu
Saint-denis-de-palin, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Corrigendum to "Uptake of HPV vaccination and associated factors in France: a nationwide study from 2007 to 2023" [Vaccine 76 (2026) 128308].
Journal: Vaccine
Published: March 01, 2026
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France.
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France.
Journal: JAMA network open
Published: December 04, 2025
Uptake of HPV vaccination and associated factors in France: a nationwide study from 2007 to 2023.
Journal: Vaccine
Published: November 28, 2025
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
Journal: JAMA
Published: August 26, 2024
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study.
Journal: Vaccine
Published: May 03, 2024
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study.
Journal: Vaccine
Published: March 28, 2024
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis.
Journal: Nature communications
Published: February 06, 2024
Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study.
Journal: Journal of infection and public health
Published: January 13, 2024
Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case-Control Study Based on the French National Health Data System.
Journal: Open forum infectious diseases
Published: April 26, 2023
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
Journal: The New England journal of medicine
Published: March 29, 2023
Last Updated: 09/26/2026